CAS: 870768-70-0

IMB-808 is an advanced synthetic compound, which is derived from a meticulously engineered chemical synthesis process. This compound functions through a unique mode of action that involves the disruption of microbial cell walls, leading to cell lysis and death. The precise mechanism involves the interference with enzymatic functions critical to cell wall biosynthesis, making it highly effective against a broad spectrum of bacterial pathogens. IMB-808 is primarily utilized in microbiological research settings to study bacterial cell wall integrity and the development of resistance mechanisms. Its applications extend to clinical research for evaluating novel treatment strategies against antibiotic-resistant strains. Due to its potent efficacy and specificity, IMB-808 is an invaluable tool in both fundamental studies and translational research aiming at the development of next-generation antimicrobials.

IMB-808 is an LXRα/β dual agonist that promotes ABCA1 expression and cholesterol efflux, used in atherosclerosis research.